Literature DB >> 10607036

Circadian and sleep/wake dependent aspects of subjective alertness and cognitive performance.

D J Dijk1, J F Duffy, C A Czeisler.   

Abstract

Circadian and sleep/wake dependent processes underlying variations in subjective alertness and cognitive performance were assessed in a constant routine protocol and in a protocol in which the sleep/wake cycle was uncoupled from the output of the endogenous circadian pacemaker. In the latter protocol, the contribution of a sleep/wake dependent process and a circadian process to alertness and performance were separated by folding the data at either the period of the sleep/wake cycle or at the period of the endogenous circadian body temperature rhythm. This analysis revealed that prior wakefulness within a range of 0-18 h significantly reduced alertness and performance and that the circadian rhythm of core body temperature paralleled the circadian rhythm of alertness and performance. During the first 16 h of the constant routine protocol, which coincided with the subjects' habitual period of wakefulness, alertness and performance remained at a stable level. The latter finding was explained by assuming that during our usual waking day the circadian system counteracts the detrimental effects of increasing duration of prior wakefulness.

Entities:  

Mesh:

Year:  1992        PMID: 10607036     DOI: 10.1111/j.1365-2869.1992.tb00021.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  127 in total

1.  The impact of a week of simulated night work on sleep, circadian phase, and performance.

Authors:  N Lamond; J Dorrian; G D Roach; K McCulloch; A L Holmes; H J Burgess; A Fletcher; D Dawson
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

2.  Work organisation and unintentional sleep: results from the WOLF study.

Authors:  Torbjorn Akerstedt; A Knutsson; P Westerholm; T Theorell; L Alfredsson; G Kecklund
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

3.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

4.  Uncovering residual effects of chronic sleep loss on human performance.

Authors:  Daniel A Cohen; Wei Wang; James K Wyatt; Richard E Kronauer; Derk-Jan Dijk; Charles A Czeisler; Elizabeth B Klerman
Journal:  Sci Transl Med       Date:  2010-01-13       Impact factor: 17.956

5.  Dynamics of neurobehavioral performance variability under forced desynchrony: evidence of state instability.

Authors:  Xuan Zhou; Sally A Ferguson; Raymond W Matthews; Charli Sargent; David Darwent; David J Kennaway; Gregory D Roach
Journal:  Sleep       Date:  2011-01-01       Impact factor: 5.849

6.  Effect of modafinil on impairments in neurobehavioral performance and learning associated with extended wakefulness and circadian misalignment.

Authors:  Scott Grady; Daniel Aeschbach; Kenneth P Wright; Charles A Czeisler
Journal:  Neuropsychopharmacology       Date:  2010-05-26       Impact factor: 7.853

7.  The association between insomnia-related sleep disruptions and cognitive dysfunction during the inter-episode phase of bipolar disorder.

Authors:  Jennifer C Kanady; Adriane M Soehner; Alexandra B Klein; Allison G Harvey
Journal:  J Psychiatr Res       Date:  2017-01-05       Impact factor: 4.791

8.  Circadian regulation of hippocampal long-term potentiation.

Authors:  Dipesh Chaudhury; Louisa M Wang; Christopher S Colwell
Journal:  J Biol Rhythms       Date:  2005-06       Impact factor: 3.182

9.  The impact of sleep timing and bright light exposure on attentional impairment during night work.

Authors:  Nayantara Santhi; Daniel Aeschbach; Todd S Horowitz; Charles A Czeisler
Journal:  J Biol Rhythms       Date:  2008-08       Impact factor: 3.182

10.  Homeostatic and circadian contribution to EEG and molecular state variables of sleep regulation.

Authors:  Thomas Curie; Valérie Mongrain; Stéphane Dorsaz; Géraldine M Mang; Yann Emmenegger; Paul Franken
Journal:  Sleep       Date:  2013-03-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.